After finishing at $0.81 in the prior trading day, Kezar Life Sciences Inc (NASDAQ: KZR) closed at $0.78, down -3.26%. On the day, 599264 shares were traded.
Ratios:
Our goal is to gain a better understanding of KZR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.66 and its Current Ratio is at 11.66. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 08, 2021, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $19.Wells Fargo initiated its Overweight rating on December 08, 2021, with a $19 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.94 while its Price-to-Book (P/B) ratio in mrq is 0.30.
Stock Price History:
Over the past 52 weeks, KZR has reached a high of $3.13, while it has fallen to a 52-week low of $0.67.
Shares Statistics:
A total of 72.78M shares are outstanding, with a floating share count of 60.02M. Insiders hold about 15.40% of the company’s shares, while institutions hold 66.78% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.25 and a low estimate of -$0.41, while EPS last year was -$0.31. The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.26 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.02 and -$1.83 for the fiscal current year, implying an average EPS of -$1.35. EPS for the following year is -$1.25, with 6 analysts recommending between -$0.85 and -$1.55.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for KZR’s current fiscal year. The highest revenue estimate was $14M, while the lowest revenue estimate was –$, resulting in an average revenue estimate of $2.33M. In the same quarter a year ago, actual revenue was $7M, down -66.70% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $3.33M in the next fiscal year. The high estimate is $20M and the low estimate is –$. The average revenue growth estimate for next year is up 42.90% from the average revenue estimate for this year.
